Investigation of the Effect of the SPOCK1 Protein Associated with Alzheimer's Disease on Apoptosis in Neuronal Cell lines

Creative Commons License

Ekenel E., Aydin Son Y., Kahraman D. C., Son Ç. D.

Alzheimer's Association International Conference 2026, London, İngiltere, 11 - 15 Temmuz 2026, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: London
  • Basıldığı Ülke: İngiltere
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Orta Doğu Teknik Üniversitesi Adresli: Evet

Özet

Abstract

 

Investigation of the Effect of the SPOCK1 Protein Associated with Alzheimer's Disease on Apoptosis in Neuronal Cell lines

 

Emilia QOMI EKENEL1, Pardis SAFARNEZHAD2, Deniz Cansen KAHRAMAN1, Çağdaş Devrim SON2,3 , Yeşim AYDIN SON1,3

1Department of Health Informatics, Graduate School of Informatics, METU, 06800, Ankara, Turkey

2Department of Biological Sciences, METU, 06800, Ankara, Turkey

3Neuroscience and Neurotechnology Center of Excellence, ODTÜ-NÖROM, Ankara, 06560, Türkiye

 

Background

Astrocyte dysfunction and cell death are increasingly recognized as key contributors to Alzheimer’s disease (AD) pathogenesis. SPOCK1, a member of the SPARC family, is highly expressed in breast, lung, prostate, and liver cancers. Several studies have reported that SPARC family proteins may play a role in the development of central nervous system (CNS) diseases. In our group’s previous studies, SPOCK1 variants were associated with late-onset Alzheimer’s disease (LOAD); however, its cell type specific functions and molecular mechanisms remain poorly understood.

Methods

 In this study, we investigated the role of SPOCK1 in regulating cell death pathways in astrocyte, microglia, and neuroblastoma cell lines, and explored its potential association with ERBB4 signaling. Using Annexin V/PI staining and analysis by flow cytometry, TUNEL assays, TMRE-based mitochondrial membrane potential measurements, caspase activity assays, and Western blot analyses.

Results

We demonstrate that SPOCK1 shows a strong pro-apoptotic effect specifically in astrocyte cells. SPOCK1 overexpression in astrocyte resulted in significantly increased apoptotic cell ratios, loss of mitochondrial membrane potential. In western blot analysis results, decreased levels of uncleaved procaspase-9 further supported activation of the intrinsic (mitochondrial) apoptotic pathway. In astroglia, SPOCK1 expression was accompanied by reduced PARP1 levels and suppression of AKT signaling, consistent with a pro-apoptotic cellular environment.

In contrast, neither SPOCK1 overexpression nor knockdown induced consistent apoptotic changes in microglia or neuroblastoma cells. Notably, SPOCK1 overexpression promoted cell proliferation in neuroblastoma cells.

Furthermore, ligand mediated ERBB4 activation significantly upregulated SPOCK1 gene expression in astroglial cells, identifying ERBB4 signaling as a potential upstream regulator of SPOCK1 in Alzheimer’s disease.

Conclusions

For the first time, these findings demonstrate that SPOCK1 selectively triggers mitochondrial apoptosis in astroglia via caspase-9 activation and AKT pathway suppression, while causing distinct effects in other neural cell types. Our study provides the first comprehensive evidence that SPOCK1 may contribute to Alzheimer’s disease pathogenesis through astrocyte-specific apoptotic mechanisms downstream of ERBB4 signaling.